1,916
Views
81
CrossRef citations to date
0
Altmetric
Review Article

Effectiveness of individual lifestyle interventions in reducing cardiovascular disease and risk factors

, &
Pages 239-251 | Published online: 08 Jul 2009

References

  • Tunstall-Pedoe H, Woodward M, Tavendale R, A'Brook R, McCluskey M K. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish heart health study: cohort study. BMJ 1997; 315: 722–9
  • Silagy C, Muir J, Coulter A, Thorogood M, Roe L. Cardiovascular risk and attitudes to lifestyle: what do patients think. BMJ 1993; 306: 1657–60
  • Johannesson M, Agewall S, Hartford M, Hedner T, Fagerberg B. The cost-effectiveness of a cardiovascular multiple-risk-factor intervention programme in treated hypertensive men. J Intern Med 1995; 237: 19–26
  • McGehee M M, Johnson E Q, Rasmussen H M, Sanyow N, Lynch M M, Carey M. Benefits and costs of medical nutrition therapy by registered dietitians for patients with hypercholesterolemia. J Am Diet Assoc 1995; 95: 1041–3
  • Arroll B, Beaglehole R. Does physical activity lower blood pressure: a critical review of the clinical trials. J Clin Epidemiol 1992; 45: 439–47
  • Atkins D, Psaty B M, Koepsell T D, Longstreth W T, Larson E B. Cholesterol reduction and the risk for stroke in men: a meta-analysis of randomised controlled trial. Ann Intern Med 1993; 119: 136–45
  • Berlin J A, Colditz G A. A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol 1990; 132: 612–28
  • Graudal N A, Galloe A M, Garred P. Effects of sodium restriction on blood pressure, renin aldosterone, cathecolamines, cholesterols and triglyseride. A meta-analysis. JAMA 1998; 279: 1383–91
  • Kelley G, McClellan P. Antihypertensive effects of aerobic exercise. A brief meta-analytic review of randomized controlled trials. Am J Hypertens 1994; 7: 115–9
  • Midgley J P, Matthew A G, Greenwood C MT, Logan A G. Effect of reduced dietary sodium on blood pressure. A meta-analysis of randomized controlled trials. JAMA 1996; 275: 1590–7
  • Muldoon M F, Manuck S B, Matthews K A. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ 1990; 301: 309–14
  • Oldridge N B, Gyatt G H, Fisher M E, Rimm A A. Cardiac rehabilitation after myocardial infarction. Combined experience of randomised clinical trials. JAMA 1988; 260: 945–50
  • Silagy C, Ketteridge S. Physician advice for smoking cessation. (Cochrane Review). The Cochrane Library, Issue 2. Oxford 1998, Update Software
  • Tang J L, Armitage J M, Lancaster T, Silagy C A, Fowler G H, Neil H AW. Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects. BMJ 1998; 316: 1213–20
  • Alderman M H. Non-pharmacological treatment of hypertension. Lancet 1994; 344: 307–11
  • Beilin L J. Non-pharmacological management of hypertension: optimal strategies for reducing cardiovascular risk. J Hypertens 1994; 12(Suppl 10)S71–81
  • Ebrahim S, Smith G D. Multiple risk factor interventions for primary prevention of coronary heart disease. (Cochrane Review). The Cochrane Library, Issue 3. Oxford 1999, Update Software
  • Guyatt G H, Sackett D L, Cook D J. Users' Guides to Medical Literature II: How to use an article about therapy or prevention. A. Are the results of the study valid. JAMA 1993; 270: 2598–601
  • Guyatt G H, Sackett D L, Cook D J. Users' Guides to the Medical Literature II: How to Use an Article About Therapy or Prevention, B. What where the results and will they help me in caring for my patients. JAMA 1994; 271: 59–63
  • Oman A D, Cook D J, Guyatt G H. Users' Guides to the Medical Literature VI: How to use an overview. JAMA 1994; 272: 1367–71
  • Oman A D, Sacket D L, Guyatt G H. Users' Guides to the Medical Literature I: How to get started. JAMA 1993; 270: 2093–5
  • Blair S N, Applegate W B, Dunn A L, Ettinger W H, Haskell W L, King A C, et al. Activity Counseling Trial (ACT): rationale design, and methods. Med Sci Sports Exerc 1998; 30: 1097–106
  • King A C, Sallis J F, Dum A L, Simons-Morton D G, Albright C A, Cohen S, et al. Overview of the Activity Counseling Trial (ACT) intervention for promoting physical activity in primary health care settings. Activity Counseling Trial Research Group. Med Sci Sports Exerc 1998; 30: 1086–96
  • Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. Family Heart Study Group. BMJ 1994; 308: 313–20
  • Pyke S D, Wood D A, Kinmonth A L., Thompson S G. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. The British Family Heart Study. Arch Family Med 1997; 6: 354–60
  • Miettinen T A, Huttunen J K, Naukkarinen V, Strandberg T, Mattila S, Kumlin T, et al. Multifactorial primary prevention of cardiovascular diseases in middle-aged men. Risk factor changes, incidence and mortality. JAMA 1985; 254: 2097–102
  • Naukkarinen V A, Strandberg T E, Vanhanen H T, Salomaa W, Sarna S J, Miettinen T A. Mortality rates after multi-factorial primary prevention of cardiovascular diseases. Ann Med 1989; 21: 441–6
  • Strandberg T E, Salomaa V V, Naukkarinen V A, Vanhanen H T, Sarna S J, Miettinen T A. Long-term mortality after multifactorial primary prevention of cardiovascular diseases in middle-aged men. JAMA 1991; 266: 1225–9
  • Strandberg T E, Salomaa W, Naukkarinen V A, Vanhanen H T, Sarna S A, Miettinen T A. Cardiovascular morbidity and multifactorial primary prevention: fifteen-year follow-up of the Helsinki Businessmen Study. Nutr Metab Cardiovasc Dis 1995; 5: 7–15
  • de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin J L, Monjaud I, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994; 343: 1454–9
  • de Lorgeril M, Salen P, Martin J L, Mamelle N, Monjaud I, Touboul P, et al. Effect of a Mediterranean type of diet on the rate of cardiovascular complications in patients with coronary artery disease. Insight into the cardioprotective effects of certain nutrients. J Am Coll Cardiol 1996; 28: 1103–8
  • Kuller L, Neaton J, Caggiula A, Falvo-Gerard L. Primary prevention of heart attacks: the multiple risk factor intervention trial. Am J Epidemiol 1980; 112: 185–99
  • Coronary heart disease death, nonfatal acute, myocardial infarction and other clinical outcomes in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Am J Cardiol 1986; 58: 1–13
  • Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group. JAMA 1982; 248: 1465–77
  • Mortality rates after 10.5 years for participants In the Multiple Risk factor Intervention Trial. Findings related to a priori hypotheses of the trial. Multiple Risk Factor Intervention Trial Research Group. JAMA 1990; 263: 1795–801
  • Hjerman I, Holme I, Velve B K, Leren B. Effect of diet and smoking intervention on the incidence of coronary heart disease. Lancet 1981; ii: 1303–10
  • Holme I, Hjermann I, Helgeland A, Leren P. The Oslo Study: diet and antismoking advice. Additional results from a 5-year primary preventive trial in middle-aged men. Prev Med 1985; 14: 279–92
  • Rose G, Colwell L. Randomised controlled trial of anti-smoking advice: final (20 year) results. J Epidemiol Community Health 1992; 46: 75–7
  • Rose G, Hamilton P J. A randomized controlled trial of the effect on middle-aged men of advice to stop smoking. J Epidemiol Community Health 1978; 32: 275–81
  • Rose G, Hamilton P JS, Colwell L, Shipley M J. A randomised controlled trial of anti-smoking advise: 10-year results. J Epidemiol Community Health 1982; 36: 102–8
  • Kumanyika S K, Hebert P R, Cutler J A, Lasser V I, Sugars C P, Steffen-Batey L, et al. Feasibility and efficacy of sodium reduction in the trials of hypertension prevention, phase I. Hypertension 1993; 22: 502–12
  • Stevens V J, Corrigan S A, Obarzanek E, Bernauer E, Cook N R, Hebert T, et al. Weight loss intervention in phase I of the Trials of Hypertension Prevention. Arch Intern Med 1993; 153: 849–58
  • The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention (TOHP), Phase I. JAMA 1992; 267: 1213–20
  • Whelton P K, Kumanyika S K, Cook N R, Cutler J A, Borhani N O, Hennekens C H, et al. Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group. Am J Clin Nutr 1997; 65(2 Suppl)652S–60S
  • Hämäläinen H, Luurila O J, Kallio V, Knuts L R, Arstila M, Hakkila J. Long-term reduction in sudden deaths after a multifactorial intervention programme in patients with myocardial infarction: 10-year results of a controlled investigation. Eur Heart J 1989; 10: 55–62
  • Kallio V, Hämäläinen H, Hakkila J, Luurila O J. Reduction in sudden deaths by a multifactorial intervention programme after acute myocardial infarction. Lancet 1979; ii: 1091–4
  • Burr M L, Gilbert J F, Holliday R M, Elwood P C, Fehily A M, Rogers S, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989; ii: 757–61
  • Carson P, Phillips R, Lloyd M, Tucker H, Neophytou M, Buch N J, et al. Exercise after myocardial infarction: a controlled trial. J R Coll Physicians Lond 1982; 16: 147–51
  • Cupples M E, McKnight A. Randomised controlled trial of health promotion in general practice for patients at high cardiovascular risk. BMJ 1994; 309: 993–6
  • Wallace P, Cutler S, Haines A. Randomised controlled trial of general practitioner intervention in patients with excessive alcohol consumption. BMJ 1988; 297: 663–8
  • Hambrecht R, Niebauer J, Marburger C, Grunze M, Kälberer B, Hauer K, et al. Various intensities of leisure time physical activity in patients with coronary artery disease: effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions. J Am Coll Cardiol 1993; 22: 468–77
  • Davis B R, Oberman A, Blaufox M D, Wassertheil-Smoller S, Zimbaldi N, Kuchner K, et al. Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. TAIM Research Group. Trial of Antihypertensive Interventions and Management. Am J Hypertens 1994; 7: 926–32
  • Langford H, Blaufox M D, Oberman A, Hawkins C M, Curb J D, Cutter G R, et al. Dietary therapy slows the return of hypertension after stopping prolonged medication. JAMA 1985; 253: 657–64
  • Singh R M, Rastogi S S, Verma R, Laxmi B, Singh R, Ghosh S, et al. Randomized controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow-up. BMJ 1992; 304: 1015–9
  • Controlled trial of soya-bean oil in myocardial infarction. Research Committee to the Medical Research Council. Lancet 1968; 2: 693–700
  • Froelicher V, Jensen D, Genter F, Sullivan M, McKirnan M D, Witztum K, et al. A randomized trial of exercise training in patients with coronary heart disease. JAMA 1984; 252: 1291–7
  • Shaw L W. Effects of prescribed supervised exercise program on mortality and cardiovascular morbidity in patients after a myocardial infarction. The National Exercise and Heart Disease Project. Am J Cardiol 1981; 48: 39–46
  • Agewall S, Wikstrand J, Samuelsson O, Persson B, Andersson O K, Fagerberg B. The efficacy of multiple risk factor intervention in treated hypertensive men during long-term follow up. J Intern Med 1994; 236: 651–9
  • Vermeulen A, Lie K I, Durrer D. Effects of cardiac rehabilitation after myocardial infarction: Changes in coronary risk factors and long-term prognosis. Am Heart J 1983; 105: 798–801
  • Niebauer J, Hambrecht R, Velich T, Marburger C, Hauer K, Kreuzer J, et al. Predictive value of lipid profile of salutary coronary angiographic changes in patients on a low-fat diet and physical exercise program. Am J Cardiol 1996; 78: 163–7
  • Meland E, Laerum E, Ulvik R J. Effectiveness of two preventive interventions for coronary heart disease in primary care. Scand J Prim Health Care 1997; 15: 57–64
  • European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6-year results. World Health Organisation European Collaborative Group. Lancet 1986; i: 869–72
  • Wood P D, Stefanick M L, Dreon D M, Frey-Hewitt B, Garay S C, Williams I T, et al. Changes in plasma lipids and lipoproteins in overweight men during weight loss trough dieting as compared with exercise. N Engl J Med 1988; 319: 1173–9
  • Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group. Arch Intern Med 1997; 157: 657–67
  • Baron J A, Gleason R, Crowe B, Mann J I. Preliminary trial of the effect of general practice based nutritional advice. Br J Gen Pract 1990; 40: 137–41
  • Fleming M F, Barry K L, Manwell L B, Johnson K, London R. Brief physician advice for problem alcohol drinkers. A randomized controlled trial in community-based primary care practices. JAMA 1997; 277: 1039–45
  • Gilbert J R, Wilson D MC, Singer J, Lindsay E A, Willms D G, Best J A, et al. A family physician smoking cessation programme: an evaluation of the role of follow-up visits. Am J Prev Med 1992; 8: 91–5
  • Haskell W L, Alderman E L, Fair J M, McMaron D J, Mackey S F, Superko H R, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease: the Stanford Coronary Risk Intervention Project SCRIP. Circulation 1994; 89: 975–90
  • The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure. Hypertension Prevention Trial Research Group. Arch Intern Med 1990; 150: 153–62
  • Stamler R, Stamler J, Gosch F C, Civinelli J, Fishman J, McKeever P, et al. Primary prevention of hypertension by nutritional-hygienic means: final report of a randomized, controlled trial. JAMA 1989; 262: 1801–7
  • Stamler R, Stamler J, Grim R, Gosh F C, Elmer P, Dyer A, et al. Nutritional therapy for high blood pressure. Final report of a four year randomized controlled trial- the hypertension control program. JAMA 1987; 257: 1484–91
  • Knutsen S F, Knutsen R. The Tromsø Survey: The Family Intervention Study-the effect of intervention on some coronary risk factors and dietary habits, a 6-year follow-up. Prev Med 1991; 20: 197–212
  • Effectiveness of health checks conducted by nurses in primary care: results of OXCHECK study after one year. Imperial Cancer Research Fund OXCHECK Study Group. BMJ 1994; 308: 308–12
  • Slama K, Redman S, Perkins J, Reid A LA, Sanson-Fisher R W. The effectiveness of two smoking cessation programmes for use in general practice: a randomised clinical trial. BMJ 1990; 300: 1707–9
  • Romelsjö A, Andersson L, Barrner H, Borg S, Granstrand C, Hultman O, et al. A randomized study of secondary prevention of early stage problem drinkers in primary health care. Br J Addict 1989; 84: 1319–27
  • Jula A, Rönnemaa T, Rastas M, Karvetti R L, Mäki J. Long-term non-pharmacological treatment for mild to moderate hypertension. J Intern Med 1990; 227: 413–21
  • Peréz-Stable E J, Coates T J, Baron R B, Biró B S, Hauck W W, McHenry K S, et al. Comparison of a lifestyle modification program with propranolol use in the management of diastolic hypertension. J Gen Intern Med 1995; 10: 419–28
  • Marra S, Paolillo V, Spadaccini F, Angelino P F. Long-term follow-up after a controlled randomized post-myocardial infarction rehabilitation programme: Effects on morbidity and mortality. Eur Heart J 1985; 6: 656–63
  • Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary prevention. Eur Heart J 1998; 19: 1413–591
  • Bucher H C, Griffith L E, Guyatt G H. Effect of HMGcoA reductase inhibitors on stroke: a meta-analysis of randomised, controlled trials. Ann Intern Med 1998; 128: 89–95

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.